Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04586335
Title Study of CYH33 in Combination With Olaparib an Oral PARP Inhibitor in Patients With Advanced Solid Tumors.
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors ShangHai HaiHe Pharmaceutical

Advanced Solid Tumor

fallopian tube cancer

peritoneum cancer

ovarian serous carcinoma


CYH33 + Olaparib

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
MD Anderson Cancer Center Recruiting Houston Texas 77030 United States Details
Integrated Oncology Network PTY LTD Recruiting Brisbane Queensland 4101 Australia Details
*Shaded cells indicate that there was no data available from for the field